AngioDynamics, Inc..
ANGO.US | Manufacture of medical and dental instruments and supplies
AngioDynamics, Inc. is a medical device company that designs, manufactures, and sells a wide range of innovative medical devices used by interventional radiologists, vascular surgeons, and other specialists for the minimally invasive treatment of peripheral vascular disease, oncology, and other non-...Show More
Better Health for All
-20
AngioDynamics' core business involves designing and manufacturing medical devices for minimally invasive treatments, such as for acute pulmonary embolism, which inherently aims to deliver substantial health benefits and improve patient outcomes.
1
The company provides risk information on its website.
2
However, AngioDynamics has had two product recalls in the past three years: one in March 2023 for 10 boxes of NanoKnife probes due to programming issues, and another in January 2024 for 600 units of vascular dilators due to manufacturing non-conformance that could delay procedures.
3
The company launched the PCTE initiative in March 2023 to increase clinical trial participation in underserved communities and educate key constituencies about clinical studies, and its website highlights the importance of including diverse patient populations in clinical trials.
4
However, the company does not provide specific data on current inclusion rates or the effectiveness of these initiatives.
5
Fair Money & Economic Opportunity
0
No evidence available to assess AngioDynamics, Inc. on Fair Money & Economic Opportunity.
Fair Pay & Worker Respect
-40
In Fiscal Year 2025, the CEO's total compensation was 44 times the median employee compensation.
1
None of the company's employees are represented by a labor union, and the company has never experienced a work stoppage.
2
In December 2014, AngioDynamics was cited for safety violations by the FDA at its manufacturing sites.
3
Employee reviews indicate an overall engagement score of 2.5 out of 5 and a culture laboral score of 2.5 out of 5.
4
One review from September 12, 2023, mentions that once hired and no longer a temp, employees receive less money per hour, implying a significant portion of the workforce is on temporary contracts.
5
Fair Trade & Ethical Sourcing
0
No specific, concrete evidence was found in the provided articles to assess AngioDynamics, Inc. against any of the KPIs for the 'Fair Trade & Ethical Sourcing' value. Information regarding fair-trade certification, audit frequency, forced/child labor incidents, supply chain traceability, remediation speed, ethical clause coverage, materials risk, or supplier diversity spend is not present. The mention of a compliance hotline does not provide data for any specific KPI.
1
Honest & Fair Business
-30
AngioDynamics has a 24/7 anonymous Compliance Hotline available for employee concerns, and policies and procedures are in place for investigating non-compliance.
1
Regular employee education and training programs are in place,
2
though program effectiveness is not publicly measured. The company asserts it has a Compliance Program (CCP) designed to prevent and detect violations, based on the AdvaMed Code of Ethics, which is considered compliant with the PhRMA Code for California purposes.
3
A Corporate Compliance Officer reports to the CEO and Board, and a management compliance committee assists in implementation.
4
Audits and risk evaluations are used to monitor compliance,
5
but training effectiveness metrics are not provided.
Kind to Animals
-60
AngioDynamics performs animal testing as part of its product design control validation procedures and in accordance with 21 CFR Part 58.
1
The company invested at least 6% of its net sales in research and development for the past three fiscal years, expecting to exceed 7% for fiscal 2004 and approximate 8% in the future, but there is no evidence that any of this budget is specifically allocated to animal-free technologies.
2
The company's president and chief executive officer serves on the strategic planning committee of the Society of Interventional Radiology, but there is no evidence of public policy engagement related to animal welfare legislation or standards.
3
No War, No Weapons
0
AngioDynamics has stated it has no direct sales to Sudan or Syria, nor any agreements with their governments or controlled entities, and is amending distribution agreements to explicitly prohibit sales to these countries and any future state sponsors of terrorism.
1
The company's Responsible Minerals Sourcing Policy aims to avoid promoting human rights violations through procurement activities, addressing risks associated with conflict minerals (tantalum, tin, tungsten, gold, cobalt) from conflict-affected and high-risk areas. However, the policy does not provide specific quantitative data on the percentage of conflict-free supply chain or procurement from conflict zones, nor does it detail the frequency of human rights due diligence. The policy also aims to avoid promoting human rights violations, which can be considered a form of ethical red lines, but no specific codification or compliance rate is provided.
Planet-Friendly Business
0
No specific, concrete data points were found in the provided articles for any of the Planet-Friendly Business KPIs. The available information explicitly indicates a lack of publicly available data for all relevant metrics, including carbon emissions, renewable energy usage, water consumption, waste diversion, and climate targets.
1
Respect for Cultures & Communities
0
No specific, concrete data points were found in the provided articles to assess AngioDynamics, Inc. against the ethical value of Respect for Cultures & Communities. The articles discuss corporate governance, employee ethics, financial information, and clinical trial initiatives focused on including underrepresented patient groups in trials. However, they do not provide evidence of formal partnerships with indigenous or local community groups, cultural impact assessments, local employment ratios, community-specific grievance mechanisms, or investments in cultural preservation.
Safe & Smart Tech
-10
The company reports no known material cybersecurity incidents and no documented incidents of unauthorized data use.
1
It conducts annual information security training, including phishing awareness, for all employees.
2
The cybersecurity risk management program is based on the NIST Cybersecurity Framework 2.0.
3
Third-party penetration testing and vulnerability testing are conducted, and third-party assessments of the cybersecurity risk management program are also performed.
4
The privacy policy states that users can access, correct, and delete their data and opt-out of marketing.
5
The company mentions compliance with GDPR, CCPA, and FDA regulations.
6
However, the company retains data for 5 years after use before archiving it.
7
Zero Waste & Sustainable Products
0
No specific, quantifiable data is available in the provided articles for any of the KPIs related to Zero Waste & Sustainable Products. The articles explicitly state that information on waste diversion rates, product recyclability, packaging sustainability, recycled content, single-use plastic reduction, take-back programs, circular design principles, waste reduction initiatives, hazardous waste management, product durability, repairability, waste audit frequency, zero waste certifications, waste disposal violations, material efficiency, packaging to product ratio, waste reduction targets, supplier waste requirements, or customer waste education programs is not publicly reported or available, indicating significant data gaps.
1